Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXCM NASDAQ:PODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXCMDexCom$76.65-1.7%$71.16$54.11▼$89.98$29.58B1.454.25 million shs5.05 million shsPODDInsulet$164.06-0.2%$153.00$138.79▼$354.88$11.36B1.111.34 million shs1.40 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXCMDexCom0.00%+2.25%+5.77%+19.80%-8.89%PODDInsulet0.00%+1.72%+12.55%-19.47%-43.09%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXCMDexCom$76.65-1.7%$71.16$54.11▼$89.98$29.58B1.454.25 million shs5.05 million shsPODDInsulet$164.06-0.2%$153.00$138.79▼$354.88$11.36B1.111.34 million shs1.40 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXCMDexCom0.00%+2.25%+5.77%+19.80%-8.89%PODDInsulet0.00%+1.72%+12.55%-19.47%-43.09%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXCMDexCom 2.89Moderate Buy$85.3611.36% UpsidePODDInsulet 2.71Moderate Buy$235.2543.39% UpsideCurrent Analyst Ratings BreakdownLatest PODD and DXCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2026DXCMDexCom Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$80.00 ➝ $87.007/15/2026DXCMDexCom MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$85.00 ➝ $90.007/13/2026PODDInsulet Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$219.00 ➝ $210.007/13/2026PODDInsulet Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$280.00 ➝ $245.007/10/2026PODDInsulet Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$250.00 ➝ $225.007/8/2026DXCMDexCom Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)7/8/2026PODDInsulet CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$165.00 ➝ $172.007/6/2026PODDInsulet EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$180.006/24/2026PODDInsulet Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)6/23/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/23/2026DXCMDexCom Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$86.00(Data available from 7/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXCMDexCom$4.82B6.14$2.77 per share27.68$7.04 per share10.89PODDInsulet$2.90B3.92$6.32 per share25.95$21.54 per share7.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXCMDexCom$836.30M$2.3432.7625.131.2619.31%33.33%13.19%7/30/2026 (Confirmed)PODDInsulet$247.10M$4.3038.1520.531.1510.44%26.87%12.01%8/5/2026 (Confirmed)Latest PODD and DXCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q2 2026PODDInsulet$1.45N/AN/AN/A$787.42 millionN/A7/30/2026Q2 2026DXCMDexCom$0.61N/AN/AN/A$1.29 billionN/A5/6/2026Q1 2026PODDInsulet$1.19$1.42+$0.23$1.30$729.89 million$761.70 million4/30/2026Q1 2026DXCMDexCom$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDXCMDexComN/AN/AN/AN/AN/APODDInsuletN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXCMDexCom0.421.951.64PODDInsulet0.712.491.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXCMDexCom97.75%PODDInsuletN/AInsider OwnershipCompanyInsider OwnershipDXCMDexCom0.28%PODDInsulet0.36%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXCMDexCom11,000385.87 million384.79 millionOptionablePODDInsulet5,40069.27 million69.02 millionOptionablePODD and DXCM HeadlinesRecent News About These CompaniesROSEN, LEADING INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODD3 hours ago | newsfilecorp.comNPODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud LawsuitJuly 18 at 2:16 PM | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODDJuly 18 at 6:18 AM | newsfilecorp.comNPODD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026July 18 at 5:35 AM | newsfilecorp.comNInsulet Corporation $PODD Shares Acquired by Fifth Third BancorpJuly 18 at 4:41 AM | marketbeat.comAware Super Pty Ltd as trustee of Aware Super Invests $3.39 Million in Insulet Corporation $PODDJuly 18 at 3:23 AM | marketbeat.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODDJuly 17 at 7:41 PM | globenewswire.comInsulet’s EVOLUTION T1D Trial Signals Next Step in Automated Insulin DeliveryJuly 17 at 12:51 PM | tipranks.comDeadline Alert: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitJuly 17 at 12:50 PM | globenewswire.comRobbins LLP Urges PODD Stockholders to Contact the Firm for Information About the Class Action Against Insulet CorporationJuly 17 at 10:15 AM | newsfilecorp.comNPODD DEADLINE: The Gross Law Firm Reminds Insulet Corporation Investors of Upcoming Securities Class Action DeadlineJuly 17 at 10:13 AM | globenewswire.comWhy Investors Need to Take Advantage of These 2 Medical Stocks NowJuly 17 at 10:01 AM | zacks.comPODD Legal Deadline Notice: Important Insulet Deadline in Securities Fraud Class Action is Approaching – Investors Notified to Contact BFA Law by August 31July 17 at 6:36 AM | globenewswire.comInsulet Corporation (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 17 at 4:43 AM | marketbeat.comC WorldWide Group Holding A S Raises Stock Position in Insulet Corporation $PODDJuly 17 at 4:31 AM | marketbeat.comROSEN, A LEADING LAW FIRM, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODDJuly 16 at 7:11 PM | newsfilecorp.comNInsulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 16 at 3:40 PM | prnewswire.comBronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor HarmJuly 16 at 12:00 PM | globenewswire.comPODD Deadline Alert: SueWallSt Reminds Insulet Corporation (PODD) Investors of Securities Class Action Deadline on August 31, 2026July 16 at 10:09 AM | prnewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODDJuly 16 at 10:00 AM | prnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insulet Corporation (PODD)July 16 at 9:16 AM | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePODD and DXCM Company DescriptionsDexCom NASDAQ:DXCM$76.65 -1.33 (-1.71%) Closing price 07/17/2026 04:00 PM EasternExtended Trading$76.36 -0.29 (-0.38%) As of 07/17/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.Insulet NASDAQ:PODD$164.06 -0.37 (-0.23%) Closing price 07/17/2026 04:00 PM EasternExtended Trading$164.10 +0.04 (+0.03%) As of 07/17/2026 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/13- 07/17 The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Wall Street Suddenly Sees SpaceX as an AI Company TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
